FilingSEC EDGAR6-K
Nyxoah Reports Q3 Revenue of €9.2 Million and PMA Supplement Submission
· SEC accepted
StageQ3 Earnings and Regulatory Progress
Filing content
Nyxoah reported Q3 2026 revenue of €9.2 million, driven by U.S. growth, and submitted a PMA supplement to the FDA to expand its Genio system indication.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…